Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Claneil Enterprises is a private investment firm and family office based in Plymouth Meeting, Pennsylvania, with a significant legacy in the pharmaceutical and healthcare sectors. The company is best known for its historical role in developing and commercializing successful dermatological products, including the head lice treatment Nix (permethrin) and the scabies treatment Elimite. Following the divestiture of its core pharmaceutical brands to companies like Warner-Lambert, Claneil transitioned into a diversified investment vehicle. Today, the firm manages a portfolio of private equity and venture capital investments, leveraging its historical expertise to support emerging companies in life sciences and consumer healthcare. It also oversees the business and philanthropic interests of the Langfitt family.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Claneil Enterprises.